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Hepatitis B virus (HBV) enhancer I has been shown to consist of several cis-acting sequences for the HBV gene expression
efficiently in certain types of cells. Transcriptional regulation of HBV X gene mediated by enhancer I might be one of the
mechanisms by which HBV obtains hepatotropism. By mutagenesis analysis of enhancer I function in the enhancer I/X
gene promoter complex, we characterized a specific transcriptional regulatory region (designated as a LSR element, nt
989–1030) of enhancer I for the X gene promoter by means of the transient transfection technique using hepatic and
nonhepatic cells. Based on the analysis of protein factors interacting with the LSR element, liver-enriched transcriptional
factors, HNF3 and HNF4 or retinoid X receptor a (RXRa), are probably implicated in the activity of enhancer I for the
efficient expression of X gene through their interaction with the LSR element in the hepatic cell. Furthermore, the isolated
LSR element was demonstrated to function alone as a specific cis-acting element and to be able to activate transcription
from the X gene promoter efficiently in the hepatic cell in an orientation-independent manner. q 1997 Academic Press
INTRODUCTION the core promoter region (Yee, 1989; Yuh and Ting, 1990).
While both enhancer I and II have been shown to exhibit
Hepatitis B virus (HBV) infection, mainly restricted to
preference for hepatic cells (Shaul et al., 1985; Jameel
hepatocytes, subsequently causes acute and chronic
and Siddiqui, 1986; Antonucci and Rutter, 1989; Yee,
hepatitis, and is thought to be closely related to the devel-
1989; Su and Yee, 1992; Yuh et al., 1992; Yuh and Ting,opment of hepatocellular carcinoma (Beasley et al., 1981;
1993), the transcriptional activities of the core and X geneTiollais et al., 1981). HBV is a small DNA virus with a
promoters have been demonstrated to be mostly regu-partially double-stranded 3.2-kb genome. The viral ge-
lated by enhancer I (Jameel and Siddiqui, 1986; Roos-nome consists of four open reading frames coding for
sinck et al., 1986; Antonucci and Rutter, 1989; Lopez-surface, core, polymerase, and X proteins (Ganem and
Cabrera et al., 1990). Nevertheless, the determinant ofVarmus, 1987). A series of genetic analyses has also
the liver-specific transcriptional activity of enhancer I hasrevealed that the genome contains four promoters and
not yet been fully analyzed in the context of the enhancertwo enhancers as cis-acting elements (Shaul et al., 1985;
I/X promoter complex. Previous studies have shown thatTognoni et al., 1985; Yee, 1989; Schaller and Fischer,
multiple trans-acting cellular factors bind to enhancer I1991). Enhancer I is located upstream of X gene and the
sequences and some of those proteins are liver-en-X promoter region (Shaul et al., 1985; Tognoni et al., 1985;
riched, however, some are ubiquitous factors (Fig. 1A)Jameel and Siddiqui, 1986). We have previously defined
(Ben-Levy et al., 1989; Ostapchuk et al., 1989; Patel etX promoter binding protein(s) (termed X-PBP), which
al., 1989; Dikstein et al., 1990; Faktor et al., 1990; Lopez-binds to the immediate downstream region (nt 1097 –
Cabrera et al., 1990; Trujillo et al., 1991; Huan and Siddi-1119) of enhancer I and the minimal X promoter se-
qui, 1992; Garcia et al., 1993; Reith et al., 1994; Ori andquence (nt 1102–1122) lacking homology to TATA box
Shaul, 1995). The expression of a number of liver-specificor GC box (Nakamura and Koike, 1992; Yaginuma et al.,
genes has been demonstrated to be regulated by interac-1993; Takada et al., 1996). We also demonstrated that
tions between some liver-enriched transcriptional fac-the element containing X-PBP binding site regulates the
tors, such as HNF1, HNF3, HNF4, and C/EBP (Mietus-activity of X promoter (Nakamura and Koike, 1992; Yagi-
Snyder et al., 1992; Gregori et al., 1993; Metzger et al.,numa et al., 1993). Enhancer II has been more recently
1993; Fuernkranz et al., 1994; Nishiyori et al., 1994; Ya-demonstrated to be located upstream of and overlaps
nuka-Kashles et al., 1994). On the basis of these findings,
some of these liver-enriched protein factors are expected1 To whom correspondence and reprint requests should be ad-
to be involved in the activity of enhancer I for the X genedressed at Department of Gene Research, The Cancer Institute (JFCR),
Kami-Ikebukuro, Toshima-ku, Tokyo 170, Japan. Fax: 81-3-5394-3902. expression in the hepatic cell.
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In this study, we characterized a specific region (desig- 10% fetal bovine serum. Saos2 cells derived from human
osteosarcoma were grown in DMEM (Nissui) containingnated as the LSR element, nt 989–1030) of enhancer I
for the efficient transcription of X gene based on the 10% fetal bovine serum. NIH3T3 cells were grown in
DMEM containing 10% calf serum.deletion analysis in the context of the enhancer I/X pro-
moter system transiently transfected into hepatic or non- Transient transfections of plasmid DNAs were per-
formed by the calcium phosphate precipitation procedurehepatic cells. The LSR element contains two protein bind-
ing sites (2C/TGT3b and GB/RARE), to which HNF3 (Chen (Graham and Van-Der-Eb, 1973). Cells were split and
plated the day before transfection at the appropriate con-et al., 1994; Ori and Shaul, 1995) and members of steroid
hormon receptor superfamily, such as HNF4, RXRa, centration for each cell line. The following day, cells were
cotransfected with a construct of CAT reporter plasmidPPAR, and COUP-TFs bind in vitro (Siddiqui, 1995), re-
spectively. Point mutations introduced in these sites re- DNA and b-galactosidase control plasmid, pCMV-b
(Clontech). The cells were incubated for 6 hr with calciumsulted in substantial diminution of the transcriptional ac-
tivity of enhancer I in the hepatic cell, but not in nonhe- phosphate precipitate and then treated with 10% glycerol
containing medium for 2.5 min. Fresh medium was thenpatic cells, indicating that these transcription factors
might be implicated in the efficient transcription of X added and total cell extracts were prepared 48 hr later.
CAT assays and b-gal assays were performed accordinggene in the hepatic cell via their interaction with the LSR
element of enhancer I. Furthermore, the isolated LSR to the published protocols (Gorman et al., 1982; Herbo-
mel et al., 1984).element was also demonstrated to function alone as a
cis-acting element, which is able to activate transcription
Nuclear extract preparation and electrophoreticfrom the X gene promoter efficiently in the hepatic cell.
mobility shift assay
MATERIALS AND METHODS Nuclear extracts were prepared according to the
method of Dignam et al. (1983). Electrophoretic mobilityPlasmid DNAs
shift assays (EMSA) were performed in a final volume of
Deletion mutations in the HBV enhancer I region [nu- 15 ml containing 5 mg of nuclear extract, 10 mM Tris–
cleotides (nt) 989–1096, HBV subtype adr (Kobayashi HCl (pH 7.5), 50 mM NaCl, 1 mM dithiothreitol, 1 mM
and Koike, 1984)] were generated from the parental plas- EDTA, 5% glycerol, 200 ng of poly (dI-dC) per ml, and
mid, pSPT18X, which contains both enhancer I and X 20,000 cpm of probe (10–30 fmol). The binding reactions
promoter region (nt 989–1250). The parental plasmid were performed at room temperature for 30 min and the
was linealized within the enhancer I region and subse- reaction products were resolved by electrophoresis on
quently deleted by the standard procedure using exo- 4% polyacrylamide gels in 0.5 1 TBE (45 mM Tris–HCl,
nuclease III and Mung bean nuclease (Takara Shuzo) pH 8.3, 45 mM borate, 2 mM EDTA) at 200 V at 47.
and then recirculurized. Fragments containing X pro-
moter region and enhancer I with various deletions in UV cross-linking assay
size were cut out from recirculurized plasmids and both
UV cross-linking analysis was performed essentiallyends of each fragment were ligated to HindIII linkers in
as previously described (Wu, 1987). To prepare the DNAorder to introduce it into the HindIII site of the expression
probe, the oligonucleotide 5*-AACGGGGTAAgctctCAGG-vector, pSV00CAT (Nippon Gene), which contains neither
3* was used as a primer and annealed to the uppertranscriptional promoter nor enhancer element except
strand of LSR-GBm (Fig. 3A). The filling-in reaction waschloramphenicol acetyltransferase (CAT) gene.
then performed at 167 for 1 hr with 8 units of KlenowPoint mutations in the LSR element of enhancer I se-
enzyme (Boehringer Mannheim) and 50 mM each ofquences of pXEPCAT were generated by using the PCR
dATP, dGTP, and Br-dUTP and 100 mCi of [a-32P]dCTP.technique. Each construct was confirmed by DNA se-
The binding reaction was performed as described abovequencing. The LSR-WT, LSR-2Cm, LSR-GBm, LSR-
for EMSA except for using 200,000 cpm for the probe.2CmGBm oligonucleotides are shown in Fig. 3A. These
The reaction mixture was then irradiated for 10 min withfragments were then cloned into 53 bp upstream the
254 nm UV light from a distance of 10 cm. The mixtureApaLI site (nt 4591 of pSV00CAT) of the expression vec-
was brought up to 25 mM CaCl2 and 5 mM MgCl2 , andtor, pXM4CAT, that contains only HBV X promoter ele-
DNA was digested with 3.75 units of DNase I (Pharmacia)ment, M4 (nt 1102–1141) (Takada et al., 1996), upstream
and 1 unit of micrococcal nuclease (Pharmacia) at 377of the CAT gene.
for 20 min and mixed with an equal volume of the sample
buffer (50 mM Tris–HCl, pH 7.5, 5 mM EDTA, 8.8% SDS,Cells and transfection
1.43 M b-mercaptoethanol, 22% glycerol, and 0.055% bro-
mophenol blue). After heat denaturation at 1007 for 5 min,HuH7 and HepG2 cells derived from human hepatocel-
lular carcinoma and human hepatoblastoma, respec- the samples were separated on a 7.5% SDS–polyacryl-
amide gel.tively, were cultured in DM-160AU (Kyokuto) containing
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FIG. 1. Deletion analysis of the HBV enhancer I activity in the enhancer I/X gene promoter complex. (A) A schematic diagram of CAT plasmid
constructs. Binding sites for the protein factors are shown on the top. X-PBP represents X promoter binding protein (Nakamura and Koike, 1992).
(B) Activity assay for various CAT plasmid constructs transiently transfected into HuH7, HepG2, Saos2, and NIH3T3 cells. The extent of acetylation
using various constructs was determined relative to that of pXEPCAT following normalization by b-gal activity. Results presented are the mean of
at least four independent experiments with standard deviation.
RESULTS resulted in an approximately 10% reduction of enhancer
activity in HepG2, 25% reduction in NIH3T3, and 40%
Assignment of a specific region of enhancer I for the reduction in Saos2 compared with pXST2CAT, whereas
efficient transcription of X gene in the hepatic cell the reduction of CAT activity in HuH7 cells was limited.
Deletion progressing from the BalI site showed that theAlthough several transcription factors could bind to
region (nt 1085–1089) containing the NF1 binding sitethe enhancer I region of HBV DNA, it is not well under-
(pXB1CAT) was not significantly involved in the enhancerstood which factors play a major role in the efficient
activity in all the cell lines used. Deletion of the se-transcription of X gene in the hepatic cell. To assess a
quences between nt 1084 and 1052 (pXB2CAT) resultedspecific transcriptional regulation of X gene with respect
in an approximately 35% reduction of CAT activity relativeto enhancer I (upstream of X-PBP), the HBV DNA frag-
to the wild-type in HuH7, NIH3T3, and Saos2 cells, andment, containing enhancer I and X promoter regions,
15% reduction in HepG2 cells. These results indicate thatwas cloned immediately upstream of the CAT reporter
the LSR element may be implicated in the specific activitygene (Fig. 1A). A set of deletion mutants in enhancer I
of enhancer I for the X gene expression in the hepaticwas then constructed and transfected into the human
cell and that the remaining region of enhancer I contrib-hepatoma cells (HuH7), the hepatoblastoma cells
uted to full enhancer activity.(HepG2), the human osteosarcoma cells (Saos2), and
NIH3T3 cells. After normalization by b-gal activity, CAT Hepatocyte-enriched transcription factors, HNF3,
activity of each deletion mutant was measured. A relative HNF4, and RXRa bind to the LSR element
CAT activity to the level of expression derived from the
wild-type plasmid, pXEPCAT, in each cell line is pre- EMSA was performed using the LSR element as a
probe to detect protein factors involved in the specificsented in Fig. 1B. Regarding the relative CAT activity of
pXEPCAT in each cell line, CAT conversion rates were function of enhancer I in the hepatic cell. It was recently
reported that in vitro synthesized HNF3 could bind to theabout 20 –30% in HuH7 cells, 5– 10% in HepG2 cells, and
1 –2% in Saos2 and NIH3T3 cells under our experimental 2C/TGT3b (2C) site (nt 994–1007) (Chen et al., 1994; Ori
and Shaul, 1995) and that members of steroid hormonconditions.
Successive deletions progressing from the StuI site receptor superfamily, such as HNF4, RXRa, PPAR, and
COUP-TFs, could bind to the GB/RARE (GB) site (nt 1010–showed that the deletion mutant of the LSR element (nt
989–1027) (pXST1CAT) reduced enhancer activity to 61% 1022) in vitro (Siddiqui, 1995). Since the LSR element
contains these binding sites, we investigated whetherin HuH7 and 70% in HepG2, whereas in Saos2 and
NIH3T3 cells this mutant exhibited no reduction of CAT these transcription factors bind to the LSR element in
HuH7 cells by means of the competition assay. For theactivity compared with the wild-type (pXEPCAT). Addi-
tional deletion of the sequences between nt 1028 and assay, oligonucleotides corresponding to each transcrip-
tion factor binding sequence were prepared (Fig. 2A).1064 (pXST2CAT) resulted in a reduction of CAT expres-
sion in all the cell lines examined. Further deletion of Three specific retarded bands were identified when the
nuclear extract from HuH7 was used (Fig. 2B). Bands Athe sequences between nt 1065 and 1095 (pXST3CAT)
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FIG. 2. Analysis of protein factors binding to the LSR element of enhancer I. (A) Sequences of oligonucleotides used in protein binding assays.
Consensus binding sequences of each protein factor are underlined. Note: Each oligonucleotide is represented as a single-strand. (B) An electropho-
retic mobility shift assay using a 32P-labeled LSR DNA probe and 5 mg of HuH7 cell nuclear extract in the presence of 100-fold molar excess of
the indicated double-stranded oligonucleotide. Arrows indicate the location of the specific DNA–protein complexes (A–C) and free probe (F).
Nuclear extract was omitted from lane 1. (C) An electrophoretic mobility shift assay using a 32P-labeled LSR DNA probe and 5 mg of nuclear extract
from the indicated cells. (D) UV cross-linking analysis of the protein binding to the 2C/TGT3b site. UV cross-linking assay using 32P-labeled LSR-
GBm oligonucleotides and nuclear extracts from the indicated cell lines was performed as described under Materials and Methods. Arrows indicate
the location of the specific DNA–protein complexes. Competitor indicates the presence or absence (0) of 100-fold molar excess of the indicated
double-stranded oligonucleotide. The size of protein molecular weight markers in kilodaltons are indicated at the left. Nuclear extract was omitted
from lane 1.
and B competed with the oligonucleotide CRBPII, repre- abundant than that of complex B when the NIH3T3 cell
nuclear extract was used. In addition, a more slowly mi-senting the high-affinity RXRa, COUP-TFs, or PPAR-bind-
ing site from the promoter of the cellular retinol binding grated band D was identified with NIH3T3 cell extract. It
is noted that the quality of each nuclear extract wasprotein II gene (Mangelsdorf et al., 1991; Kliewer et al.,
1992a, 1992b), and also by the oligo HNF4, representing verified by the quantification of the contents of ubiquitous
factors, NF1 and AP1, in each extract by virtue of EMSAthe high-affinity HNF4-binding site from the promoter of
the apolipoprotein AI gene (Fuernkranz et al., 1994). The using specific probes (data not shown).
The factor(s) binding to the 2C/TGT3b site was furtherband C competed with the oligo HNF3, representing the
high-affinity HNF3-binding site from the transthyretin pro- analyzed by the UV cross-linking assay. Electrophoretic
analysis of the samples on a 7.5% SDS–polyacrylamidemoter (Lai et al., 1990), whereas no change of the shifted
bands was observed by competition with the oligo HNF1, gel revealed that the factor may be composed of three
different proteins, whose molecular masses were esti-containing the well-characterized HNF1-binding site from
the human a1-antitrypsin promoter (Monaci et al., 1988) mated 58, 52, and 47 kDa (Fig. 2D).
(Fig. 2B).
We also performed EMSA using nuclear extracts from Effect of point mutation within the LSR element of
four different cell lines to examine whether transcription enhancer I on the X gene expression
factors interacting with the LSR element are diverse
among these cell lines. The band C corresponding to To further assess the role of the LSR element in the
transcriptional regulation of X gene, the mutant plas-HNF3 was detected with HepG2 cell nuclear extract as
well as HuH7, but not with Saos2 or NIH3T3 cell nuclear mids, each containing a point mutation within the LSR
element were generated from the parental plasmidextracts (Fig. 2C). Bands A and B, corresponding to mem-
bers of steroid hormon receptor superfamily, were de- pXEPCAT by means of the PCR method, as depicted in
Fig. 3A. Each mutant was confirmed by DNA sequencingtected with nuclear extracts from all the cell lines exam-
ined, even though the amount of complex A (E) was more and its capability of interacting with corresponding fac-
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FIG. 3. The effect of point mutations within the LSR element on its protein binding capability. (A) Sequences of the wild-type and point mutant
of the LSR element of enhancer I. (B) Mobility shift assay. The probes as indicated were incubated with nuclear extract from HepG2 or HuH7 cells.
Arrows indicate the locations of the specific DNA–protein complexes. Nuclear extract was omitted from lane 1.
tors was analyzed by EMSA using nuclear extracts from an important role in the efficient transcription of HBV X
gene in the hepatic cell.HepG2 and HuH7 cells (Fig. 3B). Consistent to the previ-
ous results in Fig. 2C, the band C corresponding to HNF3
was detected with both nuclear extracts, when LSR-WT LSR element activates the transcriptional initiation
was used as the probe, but not when mutant LSR-2Cm from the X gene promoter M4
was used. Bands, A and B, corresponding to members
of steroid hormon receptor superfamily, were detected To generate the vector which efficiently expresses X
gene in the hepatic cell, we introduced the LSR elementwith both nuclear extracts, when wild-type LSR-WT was
used as the probe, but much lesser extent when mutant into the pXM4CAT reporter, which contains only X gene
promoter region (M4, nt 1102–1141) in the pSV00CATLSE-GBm was used. No clear band was observed in
case of double mutant LSR-2CmGBm as the probe. In vector to initiate the CAT gene transcription (Fig. 5). The
LSR mutant vectors were also constructed. These ex-transient transfection assays, the point mutation in the
2C/TGT3b site (pXEP2CmCAT) reduced the level of CAT pression plasmids were transfected into each cell line
and CAT activities were measured, following normaliza-activity to 58% in HuH7 and 74% in HepG2 cells. The
mutation in the GB/RARE site (pXEPGBmCAT) also re- tion by b-gal activity. The pXM4-LSR2RCAT, which con-
tains two copies of the LSR element in an inverted orien-duced to 39% in HuH7 and 49% in HepG2, while none
of these mutations clearly affected the level of CAT activ- tation, increased the level of CAT activity by about 10-
fold compared with that of enhancer-less pXM4CAT inity in Saos2 and NIH3T3 cells (Fig. 4). These findings
again indicate that the LSR element of enhancer I plays HuH7 cells (Fig. 5). Three copies of the LSR element
FIG. 4. Contribution of the LSR element of enhancer I to the expression of X gene in the context of the enhancer I/X promoter complex. A
schematic diagram of CAT constructs used is shown on the left. The point mutation in the LSR element was introduced into the pXEPCAT. Diamonds
indicate the mutation sites. Activities of various CAT plasmid constructs transiently transfected into HuH7, HepG2, Saos2, and NIH3T3 cells are
shown on the right. The extent of acetylation using various constructs was determined relative to that of pXEPCAT following normalization by b-
gal activity. Results are presented as the mean of at least four independent experiments with standard deviation.
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FIG. 5. Enhancer activity of the multimerized LSR element. The multimerized LSR element was introduced into the pXM4CAT which only contains
the X gene basal promoter M4 to initiate the CAT gene transcription. 2Cm, GBm, or 2CmGBm represents the point mutant within the 2C/TGT3b,
GB/RARE, or both sites, respectively. The arrows indicate the relative orientation of each fragment to the direction of transcription. Activities of
various CAT plasmid constructs transiently transfected into HuH7, HepG2, Saos2, and NIH3T3 cells are shown on the right. The extent of acetylation
in various reactions was determined relative to that of pXM4CAT following normalization by b-gal activity. Results are presented as the mean of
at least four independent experiments with standard deviation. ND, not determined.
activated transcription from X gene promoter M4 by ap- cell. The deletion of LSR element reduced the activity of
proximately 20-fold in HuH7 cells (pXM4-LSR3CAT). enhancer I in hepatic cells, but not in nonhepatic cells
These constructs exhibited a slight increase of CAT activ- (Fig. 1). Based on the previous reports, the LSR element
ity in HepG2 cells (Fig. 5). An exact reason why HepG2 contains two protein binding sites; 2C/TGT3b site inter-
cell line responded in a lesser extent to these constructs acting with HNF3 (Chen et al., 1994; Ori and Shaul, 1995),
than HuH7 cell line is not known. This transcriptional and GB/RARE site interacting with members of steroid
activation was not due to nonspecific effect, because the hormon receptor superfamily (Huan and Siddiqui, 1992;
CAT activity of the LSR mutants remained at the basal Garcia et al., 1993; Huan et al., 1995). The point mutation
level. Interestingly, none of these constructs containing in either site resulted in substantial diminution of the
the LSR element showed enhanced levels of CAT activity transcriptional activity of enhancer I in hepatic cells, but
in Saos2 or NIH3T3 cells compared with that of the not in nonhepatic cells (Fig. 4).
pXM4CAT (Fig. 5). These results clearly indicate that the The HNF3 family is composed of three isoforms
LSR element can activate transcription from X gene pro- (HNF3a, HNF3b, and HNF3g) (Lai et al., 1991), all of
moter M4 efficiently in the hepatic cell in an orientation- which are expressed mainly in the liver and gut and
independent manner. participate in the activation of liver-specific gene tran-
scription by recognizing their target sequences as mono-
DISCUSSION mers. Those HNF3 binding sites have been described in
the regulatory regions of the albumin (Jackson et al.,HBV genome replication and gene expression in the
1993), transthyretin (TTR) (Costa et al., 1989), transferrinhepatic cell are known to be facilitated by enhancer I and
(Auge-Gouillou et al., 1993), phosphoenolpyruvate car-previous studies have shown that enhancer I exhibited a
boxykinase (PEPCK) (Ip et al., 1990), aldolase B (Ray-preference for the hepatic cell and mostly affected the
mondjean et al., 1991) genes, and in duck hepatitis Bactivity of the core/pregenomic and X promoters (Shaul
virus enhancer (Liu et al., 1994), as well. Electrophoreticet al., 1985; Jameel and Siddiqui, 1986; Roossinck et al.,
mobility shift assays revealed that HNF3 factors likely1986; Antonucci and Rutter, 1989; Lopez-Cabrera et al.,
exist in the nuclear extracts of HuH7 and HepG2, but not1990). Although several binding sites for transcription
in Saos2 nor NIH3T3, and bound to the HS site of en-factors including both liver-enriched and ubiquitous fac-
hancer I (Fig. 2). According to the intensity of the signals,tors have been identified in enhancer I, a specific deter-
however, the amount of HNF3 factors in HepG2 may beminant for the X gene expression in the hepatic cell has
less than those in HuH7 (Fig. 2C). In addition, the resultnot yet been well analyzed, especially in the context of
of UV cross-linking analysis suggested that three iso-the enhancer I/X promoter complex. In this study we
forms of the HNF3 family might be expressed in HuH7,elucidated the LSR element of enhancer I mainly involved
in the efficient transcription of X gene in the hepatic but only two isoforms in HepG2, although we could not
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achieve further characterization of these factors in this tocellular carcinoma tissue in origin was higher than in
HepG2 cells from the hepatoblastoma. In fact, we haveinquiry. Along with the results of mutation analysis, our
findings imply that HNF3 may be implicated in the tran- previously demonstrated that the efficiency of HBV gene
transcription was higher in HuH7 cells than in HepG2scriptional activation of HBV gene via its interaction with
the 2C/GB site of enhancer I. cells, when pHBV-2 DNA (about 1.3 genome in size) was
transfected into these two cell lines (Yaginuma et al.,It is known that RXRa and HNF4 are expressed at
higher levels in liver tissue than in other tissues (Sladek 1987). It is further noted that this activation was com-
pletely obliterated by mutation in either the 2C/TGT3b oret al., 1990; Mangelsdorf et al., 1992) and can bind as
homodimers to a DR1 element and function as strong GB/RARE site alone. Data suggest that both factors bind-
ing to 2C/TGT3b and GB/RARE sites might be requiredconstitutive transcriptional activators (Jiang et al., 1995).
PPAR is also a liver-enriched nuclear receptor and can to activate transcriptional regulation of X gene promoter.
Since mutation in either site (2C/TGT3b or GB/RARE site)bind as a heterodimer with RXRa to a DR1 and function
as a transcriptional activator (Kliewer et al., 1992b). On did not affect the factors binding activity of the other
site in the electrophoretic mobility shift assay (data notthe other hand, COUP-TFs are ubiquitous factors and
can bind as a heterodimer with RXRa to a DR1 and func- shown), interaction between these factors is not likely to
occur at least in vitro. One possible explanation is thattion as potent dominant repressors of both basal tran-
scription and transactivation by RXRa (Kliewer et al., this transcriptional activation may be due to stabilization
of the basal transcriptional factor complex by both fac-1992a; Ben-Shushan et al., 1995). On the basis of this
knowledge, HNF4, PPAR, and RXRa could function as tors, as reported previously (Sauer et al., 1995). To know
whether or not these factors function as cooperativetranscriptional activators for HBV X gene in the hepatic
cell by overcoming the repression activity of COUP-TFs, trans-acting factors on the X gene promoter, further in-
vestigation is required.while the transcriptional activity of the GB/RARE site
might be suppressed by COUP-TFs in nonhepatic cells, In conclusion, we elucidated that the LSR element of
enhancer I plays a major role in the efficient transcriptionin which the expression of HNF4, PPAR, or RXRa is ex-
tremely limited. Taken together, both of the factors bind- of the HBV X gene in the hepatic cell in the context of
enhancer I/X promoter complex. It was also suggesteding to the 2C/TGT3b and GB/RARE sites of enhancer I
are very likely to contribute to efficient transcription of that hepatocyte-enriched transcription factors, HNF3,
HNF4, and RXRa are very likely to facilitate the efficientHBV X gene in the hepatic cell.
In regard to the remaining part of enhancer I other transcription from the X gene promoter via their interac-
tion with the LSR element in the hepatic cell.than the LSR element, many transcriptional factors have
been demonstrated to bind to their respective binding
sites (Ben-Levy et al., 1989; Ostapchuk et al., 1989; Patel ACKNOWLEDGMENTS
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